why choose us

First received: March 16, 2023

Clinical Trial: A Study of SerpinPC in Participants With Hemophilia B (HemB) With Inhibitors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hemophilia B With Inhibitor

Study Type: INTERVENTIONAL


Official Title: A Global, Open-label Study to Investigate the Efficacy and Safety of SerpinPC in Subjects With Hemophilia B With Inhibitors

Brief Summary: The purpose of the study is to evaluate the efficacy, safety, tolerability and pharmacokinetic (PK) profile of prophylactic SerpinPC in participants with Hemophilia B with inhibitors, as part of the SerpinPC registrational program.

Read more